20 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... anticoagulants (DOACs ... Table #DOAC ... Anticoagulants #Anticoagulation ... #Table
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... #DOAC #Dosing #Oral ... #Anticoagulation ... #Comparison #Table
Pharmacokinetic Characteristics and Primary Routes of Clearance of Oral Anticoagulant Agents

Warfarin - 100% Hepatic, 0% Renal
Apixaban
of Clearance of Oral ... , 35% Renal #DOAC ... #NOAC #Metabolism ... Pharmacology #Clearance #oral ... #anticoagulation
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Molecular Weight Heparin ... - Dabigatran #anticoagulation ... #medications #doac ... #comparison #table
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... direct-acting oral ... molecular weight heparin ... #Cancer #Algorithm ... #Anticoagulation
Oral Anticoagulation Management Cheat Sheet: Warfarin, Apixaban, Dabigatran, Rivaroxaban
 - Mechanism of Action
 - Routine Blood
Oral Anticoagulation ... - Resume #Oral ... #Anticoagulation ... Anticoagulant #DOAC ... #Management #Table
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Heparin, Fondaparinux ... Pathophysiology Anticoagulation ... warfarin) for chronic anticoagulation ... Heparins #LMWH #UFH #DOAC ... #Fondaparinux #NOAC
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Management of DOACs ... patients on chronic anticoagulation ... direct acting oral ... per treatment table ... may not require anticoagulation
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... utilize direct oral ... anticoagulants (DOACs ... #INR #Target #DOAC ... #Table #Replacement
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... DOAC, direct oral ... low-molecular-weight heparin ... #DOAC #VTE #Malignancy ... #Anticoagulation